Dr. Singh on Patient Selection for Immunotherapy in Bladder Cancer – OncLive
OncLive |
Dr. Singh on Patient Selection for Immunotherapy in Bladder Cancer
OncLive Parminder Singh, MD, Hematologist/Oncologist, Mayo Clinic, discusses treatment selection for patients with bladder cancer. At this point, patient selection is based on the approval or labeling indications of the drug, where the patient lies in the … |
